Global Oligonucleotide Pool Market to Reach USD 2,697.52 Million by 2032 | CAGR of 5.2%
Category : Pharmaceuticals | Published Date : Jan 2025 | Type : Press Release
Oligonucleotide Pool Market Scope & Overview:
In the newly published report, Consegic Business Intelligence states that the Oligonucleotide Pool Market was valued at USD 1,825.20 million in 2024 and is projected to grow at a CAGR of 5.2%, reaching USD 2,697.52 million by 2032. Oligonucleotide pools are complex mixtures of synthetic DNA or RNA molecules used in genomic applications such as gene synthesis, next-generation sequencing (NGS), and genetic testing. These pools are essential for advancing research, diagnostics, and therapeutic developments, supported by innovations in synthesis technologies.
The report comprises the Oligonucleotide Pool Market Share, Size & Industry Analysis, based on Type (DNA, RNA), Application (Gene Synthesis, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Genetic Testing, Others), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), and Region (North America, Europe, Asia-Pacific, Middle East & Africa, Latin America), and Forecast, 2025-2032.
The report contains detailed information on Oligonucleotide Pool Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profiles, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
Segmental Analysis :
Based on type, the market is bifurcated into DNA and RNA.
- The DNA segment accounted for the largest market share in 2024, driven by its extensive applications in CRISPR library construction, gene synthesis, and genetic data storage. Advanced synthetic techniques enable simultaneous generation of multiple sequences, enhancing efficiency in molecular biology research.
- The RNA segment is projected to grow at the fastest rate, fueled by its role in gene silencing, RNA interference (RNAi), and studies on RNA-protein interactions.
Based on application, the market is segmented into Gene Synthesis, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Genetic Testing, and Others.
- The Polymerase Chain Reaction (PCR) segment held the largest market share in 2024, driven by its utility in multiplex PCR assays for pathogen detection and genetic screening. Oligonucleotide pools enhance the accuracy and throughput of these applications.
- The Next-Generation Sequencing (NGS) segment is expected to grow at the fastest rate, supported by its use in library preparation, target enrichment, and amplicon sequencing, ensuring higher efficiency and specificity in genomic research.
Based on end user, the market is segmented into Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, and Others.
- The Pharmaceutical & Biotechnology Companies segment dominated the market in 2024, attributed to their use of oligonucleotide pools in drug discovery, gene therapy, and CRISPR-based technologies. These pools are critical in advancing personalized medicine and therapeutic innovations.
- The Diagnostic Laboratories segment is anticipated to register the highest CAGR, driven by the increasing demand for advanced diagnostic tools such as multiplex PCR assays and CRISPR-based diagnostics.
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- North America led the market in 2024, with a valuation of USD 743.77 million, driven by strong R&D activities, a robust biotechnology sector, and well-established healthcare infrastructure.
- Asia-Pacific is projected to grow at the fastest rate, with a CAGR of 5.6%, supported by rising investments in genomics, advancements in molecular biology research, and the growing biotechnology industry.
| Report Attributes | Report Details |
| Study Timeline | 2019-2032 |
| Market Size in 2032 | USD 2,697.52 Million |
| CAGR (2025-2032) | 5.2% |
| Type | DNA, RNA |
| Application | Gene Synthesis, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Genetic Testing, Others |
| End-User | Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, aftermarket service providers, industry giants, and niche players, all of which are thoroughly examined by Consegic Business Intelligence in terms of their strengths, weaknesses, and value-addition potential. This report includes detailed profiles of key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging partnership trends and dynamics.
List of prominent players in the Oligonucleotide Pool Industry:
- Creative Biogene (U.S.)
- Agilent Technologies (U.S.)
- Integrated DNA Technologies, Inc. (U.S.)
- GenScript (U.S.)
- Twist Bioscience (Canada)
- LC Sciences (U.S.)
- Illumina (U.S.)
- CustomArray (U.S.)
- Sigma Aldrich (U.S.)
- TriLink BioTechnologies (U.S.)
Recent Industry Developments :
- October 2024: Illumina introduced the MiSeq i100 Series sequencing systems, accelerating workflows for NGS applications, enabling same-day results, and optimizing oligonucleotide pool designs.
- April 2021: Biolytic Lab Performance launched the Dr. Oligo 192XLc High-Throughput Oligo Synthesizer, offering high-quality oligonucleotide synthesis with reduced reagent consumption.
